[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100605303":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":15,"locations":21,"responsibleParty":40,"collaborators":42,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":54,"sex":55,"minAge":56,"maxAge":10,"enrollmentInfo":57,"targetDuration":10,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":68,"overallStatus":73,"whyStopped":10,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"Semikal Technology","INDUSTRY",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Cross-linked hyaluronic acid based adhesion barrier gel",null,"Operative hysteroscopy plus adhesion barrier gel",{"label":13,"type":10,"description":14,"interventionNames":10},"Control group (none)","Operative hysteroscopy alone as control group",[16],{"name":17,"role":18,"phone":19,"phoneExt":10,"email":20},"Aslıhan Kara Study Director","CONTACT","+90 246 237 01 01","info@semical.com.tr",[22],{"facility":23,"status":10,"city":24,"state":10,"zip":25,"country":26,"countryCode":10,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Antalya Training and Research Hospital Gynecology and Obstetrics Clinic","Antalya","07100","Turkey (Türkiye)",{"type":28,"coordinates":29},"Point",[30,31],30.69556,36.90812,{"lat":31,"lon":30},[34,37],{"name":35,"role":18,"phone":36,"phoneExt":10,"email":10},"Burak Karadağ Prof.Dr","0090 242 249 44 00",{"name":38,"role":39,"phone":10,"phoneExt":10,"email":10},"Burak Karadağ Prof. Dr.","PRINCIPAL_INVESTIGATOR",{"type":41,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[43],{"name":44,"class":45},"Antalya Training and Research Hospital","OTHER_GOV","100605303","safety-and-performance-of-the-semical-adhesion-barrier-gel-for-prevention-of-intra-uterine-adhesion-100605303",false,"NCT07160764","Safety and Performance of the Semical Adhesion Barrier Gel for Prevention of Intra-uterine Adhesion","Evaluation of Performance and Safety of Hyalosem Cross-linked Hyaluronic Acid Adhesion Barrier Gel in Preventing Intra-uterine Adhesion Formation After Operative Hysteroscopy: A Retrospective Study","SEMFERTIL","Inclusion Criteria:\n\n* Female patients aged 18 and over\n* Patients who were treated with operative hysteroscopy for intrauterine pathology (endometrial polips, myomas with uterine cavity deformation, uterine septa, intrauterine adhesion, ovarian cyst, endometrial cyst, etc.)\n* Patients who had undergone operative hysteroscopy at least 30 days and at most 6 months ago\n* Patients who had second-look office hysteroscopy at least once after an operative hysteroscopy\n\nExclusion Criteria:\n\n* Children and adolescents under 18 years of age\n* Having a body weight of more than 100 kg\n* Surgeries complicated by excessive bleeding; estimated blood loss of more than 100 cc\n* Surgeries complicated with uterine perforation\n* Presence of uncontrolled diabetes, coagulation disorders, and other severe chronic disorders\n* Presence of malignant tumor or diagnosis of cancer, presence of uterovaginal prolapse\n* Concomitant peritoneal grafting or tubal implantation\n* Concomitant intrauterine device implantation\n* Patients without second-look hysteroscopy\n\nAccording to the GDPR and clinical investigation legislation, written informed consent is not mandatory in retrospective studies as long as the patient's personal information is censored.",true,"FEMALE","18 Years",{"count":58,"type":59},80,"ESTIMATED","OBSERVATIONAL","The aim of this study was to obtain short- and long-term performance and safety data of cross-linked hyaluronic acid-based adhesion barrier gel used to prevent intrauterine adhesion formation.",[63,64,65,66,67],"Intrauterine Abnormalities in Infertility","Asherman Syndrome","Intra-uterine Adhesions","Postoperative Adhesion of Uterus","Asherman's Syndrome",[69,70,71,72],"intrauterine abnormalities","asherman's syndrome","intrauterine adhesions","postoperative adhesions","NOT_YET_RECRUITING","2025-09-01",{"date":76,"type":77},"2025-09-08","ACTUAL",{"date":79,"type":59},"2025-11-01",{"date":81,"type":59},"2025-12-31",{"name":5,"class":6},1]